Brain Cancer Archives - Page 2 of 2 - NFCR

Brain Cancer

“Pink Drink” to Aid Brain Tumor Treatment

Approved in June 2017 by the U.S. Food and Drug Administration and launched commercially in-country in October 2018, 5-Aminolevulinic Acid (also known as 5-ALA, and composed of aminolevulinic acid hydrochloride) is an optical imaging agent for use in patients with high-grade gliomas. Nicknamed the “pink drink,” 5-ALA is a surgical…...

Read more

Brain Cancer Awareness Month

In recognition of Brian Cancer Awareness Month, the National Foundation for Cancer Research today offers up a rather in depth overview of a handful of innovative technologies being explored in labs to address the terrible disease class. Although brain cancer only makes up 1.4% of all new cancer cases, the…...

Read more

Medical Coalition Led Largely by NFCR Unites to Battle Glioblastoma

Medical knowledge of glioblastoma multiforme (GBM), the deadliest form of brain cancer, has grown exponentially, but has not resulted in marked improvements in treatment for patients. Addressing this is GBM AGILE (GBM Adaptive Global Innovative Learning Environment), a global medical and scientific coalition that is the first platform trial for…...

Read more

Brain Cancer Surgery: Thriving in Recovery

Brain cancer is a formidable adversary in the world of oncology. Against substantial odds, patients work with dedicated doctors to mount a counter offensive. The road to recovery is, to no one’s astonishment, arduous, as brain surgery exposes the very epicenter of our being, behavior, personality, motor skills and memory.…...

Read more

4 Must-Know Facts About the Deadliest Brain Tumor

Glioblastoma multiforme—also known as GBM—is the most lethal form of brain cancer in adults. This devastating brain cancer spreads into other parts of the brain very quickly and is usually not surgically curable. Typically, radiation and chemotherapy are given with the hopes of delaying tumor progression. If you or a loved…...

Read more

7 Facts You Need to Know About Brain Tumors

What is Brain Tumor? Of the nearly 80,000 brain tumors diagnosed in the U.S. each year, approximately 32% are considered malignant – or cancerous. Overall, the chance that a person will develop a malignant tumor of the brain or spinal cord in his or her lifetime is less than 1%.…...

Read more

NFCR’s Genomics Newsroom: New genes linked to increased risk of ovarian and brain cancer

What is “genomics”? Cancer develops when genetic material (DNA) becomes damaged or changed. We know some cancer causing genetic changes are acquired (i.e. smoking), while others are inherited. Studying cancer genomics explores the differences between cancer cells and normal cells. Advances in understanding how cancer behaves at a genomic and…...

Read more

New Treatment for Glioblastoma Multiforme Developed by NFCR Scientists

Dr. Web Cavenee and Dr. Paul B. Fisher discover a new pharmacological agent to treat glioblastoma multiforme (GBM), the deadliest brain cancer....

Read more